Neuralink is set to commence high-volume production of its brain-computer interface devices in 2026. The company plans to implement a streamlined, largely automated surgical procedure that allows device threads to pass through the dura without removal. This advancement marks a significant step in the development of Neuralink's technology, potentially enhancing the accessibility and efficiency of brain-computer interface surgeries.